VistaGen Therapeutics Receives $1,570,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7dae8dee-0dc2-4a0e-8b0c-94337d82139c - Date
7/1/2014 - Company Name
VistaGen Therapeutics - Mailing Address
343 Allerton Avenue South San Francisco, CA 94080 USA - Company Description
VistaGen Therapeutics is a biopharmaceutical company pioneering the use of embryonic stem cells (ES cells) for drug discovery and development and predictive toxicology. - Website
http://www.vistagen.com - Transaction Type
Debt - Transaction Amount
$1,570,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
